Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer
- 1 July 2014
- journal article
- Published by S. Karger AG in Oncology
- Vol. 87 (2), 125-132
- https://doi.org/10.1159/000361051
Abstract
Background: The development of distant metastases of squamous cell carcinoma of the anal canal (SCCA) is rare but has a poor prognosis. A combination of carboplatin and paclitaxel is commonly used for treating squamous cell cancer in different organs, but its efficacy in advanced SCCA is unclear. The objective of this study is to determine the tolerability and outcome of patients with advanced SCCA on carboplatin plus paclitaxel treatment at the Moffitt Cancer Center. Methods: Retrospective analysis was conducted by looking at records from the Moffitt Cancer Center Tumor Registry from January 2007 to January 2012. Eligible patients had to have a diagnosis of SCCA and have received carboplatin plus paclitaxel every 3 weeks as part of the treatment plan. Results: Eighteen patients fulfilled the criteria; 14 were initially diagnosed with early-stage disease and received concurrent chemoradiation, but then relapsed. Median age was 56 years. Upon diagnosis of metastatic disease, 12 patients received carboplatin plus paclitaxel as a first-line treatment. Five patients had received prior systemic chemotherapy regimens and 1 had received prior local regional therapy. The response rate was high at 53% including 3 patients who achieved a complete response. Median overall survival was 12.19 months. Conclusions: Carboplatin and paclitaxel treatment shows encouraging activity in advanced SCCA.Keywords
This publication has 16 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neckAnnals of Oncology, 2011
- Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational StatusOncology, 2009
- Liver-Directed Surgery for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center AnalysisAnnals of Surgical Oncology, 2007
- Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282Investigational New Drugs, 2006
- Epidermal Growth Factor Receptor Expression in Anal Canal CarcinomaAmerican Journal of Clinical Pathology, 2005
- Human papillomavirus, smoking, and sexual practices in the etiology of anal cancerCancer, 2004
- Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosisNature Medicine, 1996
- Anal human papillomavirus infection and anal cancer in HIV-positive individualsAIDS, 1994
- Treatment of Relapsing Anal CarcinomaActa Oncologica, 1993